Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Short Interest Update

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) was the target of a large growth in short interest in the month of July. As of July 15th, there was short interest totalling 492,300 shares, a growth of 19.9% from the June 30th total of 410,600 shares. Based on an average daily volume of 54,600 shares, the short-interest ratio is currently 9.0 days. Approximately 1.6% of the company’s stock are short sold.

Institutional Trading of Bioceres Crop Solutions

A number of institutional investors have recently modified their holdings of the company. Activest Wealth Management acquired a new stake in Bioceres Crop Solutions in the 1st quarter worth approximately $30,000. Cape Investment Advisory Inc. acquired a new stake in Bioceres Crop Solutions in the 4th quarter worth approximately $33,000. Oppenheimer & Co. Inc. acquired a new stake in Bioceres Crop Solutions in the 1st quarter worth approximately $139,000. Lazard Asset Management LLC acquired a new stake in Bioceres Crop Solutions in the 1st quarter worth approximately $212,000. Finally, One Degree Advisors Inc acquired a new stake in Bioceres Crop Solutions in the 4th quarter worth approximately $291,000. 17.68% of the stock is currently owned by institutional investors.

Bioceres Crop Solutions Stock Down 0.5 %

Shares of NASDAQ:BIOX traded down $0.05 during trading on Monday, reaching $11.00. The stock had a trading volume of 108,194 shares, compared to its average volume of 58,501. Bioceres Crop Solutions has a one year low of $10.10 and a one year high of $14.05. The company has a market capitalization of $690.80 million, a P/E ratio of 1,100.00 and a beta of 0.50. The company has a current ratio of 1.22, a quick ratio of 0.83 and a debt-to-equity ratio of 0.29. The firm’s 50-day simple moving average is $11.00 and its 200 day simple moving average is $12.18.

Bioceres Crop Solutions (NASDAQ:BIOX) last released its quarterly earnings results on Wednesday, May 29th. The company reported $0.14 earnings per share for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.02). Bioceres Crop Solutions had a net margin of 0.21% and a return on equity of 0.28%. The firm had revenue of $83.98 million during the quarter, compared to the consensus estimate of $88.80 million. As a group, research analysts expect that Bioceres Crop Solutions will post 0.35 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on the stock. Canaccord Genuity Group reissued a “buy” rating and set a $17.00 target price on shares of Bioceres Crop Solutions in a research report on Friday, July 19th. Roth Mkm assumed coverage on shares of Bioceres Crop Solutions in a research report on Tuesday, July 2nd. They set a “buy” rating and a $15.00 target price on the stock. Roth Capital raised shares of Bioceres Crop Solutions to a “strong-buy” rating in a research report on Tuesday, July 2nd. Finally, Canaccord Genuity Group raised shares of Bioceres Crop Solutions to a “strong-buy” rating in a research report on Friday, July 19th. Three analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus target price of $19.00.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.